title: Biomarkers in clinical trials: can we move from fortune telling to disease profiling?
authors.forename: James A
authors.initials: JA
authors.lastname: de Lemos
authors.forename: Darren K
authors.initials: DK
authors.lastname: McGuire
mesh_terms: D015415:Biomarkers / Q000097:blood; D001798:Blood Proteins / Q000032:analysis; D015992:Body Mass Index; D002318:Cardiovascular Diseases / Q000097:blood / Q000453:epidemiology; D002986:Clinical Trials as Topic / Q000379:methods* / Q000706:statistics & numerical data; D015986:Confounding Factors, Epidemiologic; D003924:Diabetes Mellitus, Type 2 / Q000097:blood / Q000188:drug therapy; D006801:Humans; D007004:Hypoglycemic Agents / Q000494:pharmacology / Q000627:therapeutic use; D007249:Inflammation / Q000097:blood; D010641:Phenotype; D011379:Prognosis; D018570:Risk Assessment
chemical_list: D015415:Biomarkers; D001798:Blood Proteins; D007004:Hypoglycemic Agents